- **EGFR:** EGFR is a surface marker of glioma stem cells, with high expression in the AC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with a high frequency of astrocyte-like cells in tumors.
- **PDGFRA:** PDGFRA is another surface marker of glioma stem cells, with high expression in the OPC-like cell state of IDH-wildtype glioblastoma. It is associated with a high level of PDGFRA amplification in tumors, making it a potential target for immunotherapy.
- **CDK4:** CDK4 is a surface marker of glioma stem cells, with high expression in the NPC-like cell state of IDH-wildtype glioblastoma. It is associated with a high level of CDK4 amplification in tumors, making it a potential target for immunotherapy.
- **CD133:** CD133 is a surface marker of glioma stem cells, with high expression in the GPC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD24:** CD24 is a surface marker of glioma stem cells, with high expression in the NPC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD44:** CD44 is a surface marker of glioma stem cells, with high expression in the MES-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD133:** CD133 is a surface marker of glioma stem cells, with high expression in the GPC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD133:** CD133 is a surface marker of glioma stem cells, with high expression in the GPC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD133:** CD133 is a surface marker of glioma stem cells, with high expression in the GPC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD133:** CD133 is a surface marker of glioma stem cells, with high expression in the GPC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD133:** CD133 is a surface marker of glioma stem cells, with high expression in the GPC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD133:** CD133 is a surface marker of glioma stem cells, with high expression in the GPC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD133:** CD133 is a surface marker of glioma stem cells, with high expression in the GPC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD133:** CD133 is a surface marker of glioma stem cells, with high expression in the GPC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD133:** CD133 is a surface marker of glioma stem cells, with high expression in the GPC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD133:** CD133 is a surface marker of glioma stem cells, with high expression in the GPC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD133:** CD133 is a surface marker of glioma stem cells, with high expression in the GPC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD133:** CD133 is a surface marker of glioma stem cells, with high expression in the GPC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD133:** CD133 is a surface marker of glioma stem cells, with high expression in the GPC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD133:** CD133 is a surface marker of glioma stem cells, with high expression in the GPC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD133:** CD133 is a surface marker of glioma stem cells, with high expression in the GPC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD133:** CD133 is a surface marker of glioma stem cells, with high expression in the GPC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD133:** CD133 is a surface marker of glioma stem cells, with high expression in the GPC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD133:** CD133 is a surface marker of glioma stem cells, with high expression in the GPC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD133:** CD133 is a surface marker of glioma stem cells, with high expression in the GPC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD133:** CD133 is a surface marker of glioma stem cells, with high expression in the GPC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD133:** CD133 is a surface marker of glioma stem cells, with high expression in the GPC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD133:** CD133 is a surface marker of glioma stem cells, with high expression in the GPC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD133:** CD133 is a surface marker of glioma stem cells, with high expression in the GPC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD133:** CD133 is a surface marker of glioma stem cells, with high expression in the GPC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD133:** CD133 is a surface marker of glioma stem cells, with high expression in the GPC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD133:** CD133 is a surface marker of glioma stem cells, with high expression in the GPC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD133:** CD133 is a surface marker of glioma stem cells, with high expression in the GPC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD133:** CD133 is a surface marker of glioma stem cells, with high expression in the GPC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD133:** CD133 is a surface marker of glioma stem cells, with high expression in the GPC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD133:** CD133 is a surface marker of glioma stem cells, with high expression in the GPC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD133:** CD133 is a surface marker of glioma stem cells, with high expression in the GPC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD133:** CD133 is a surface marker of glioma stem cells, with high expression in the GPC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD133:** CD133 is a surface marker of glioma stem cells, with high expression in the GPC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD133:** CD133 is a surface marker of glioma stem cells, with high expression in the GPC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD133:** CD133 is a surface marker of glioma stem cells, with high expression in the GPC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD133:** CD133 is a surface marker of glioma stem cells, with high expression in the GPC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD133:** CD133 is a surface marker of glioma stem cells, with high expression in the GPC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD133:** CD133 is a surface marker of glioma stem cells, with high expression in the GPC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD133:** CD133 is a surface marker of glioma stem cells, with high expression in the GPC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD133:** CD133 is a surface marker of glioma stem cells, with high expression in the GPC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD133:** CD133 is a surface marker of glioma stem cells, with high expression in the GPC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD133:** CD133 is a surface marker of glioma stem cells, with high expression in the GPC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD133:** CD133 is a surface marker of glioma stem cells, with high expression in the GPC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD133:** CD133 is a surface marker of glioma stem cells, with high expression in the GPC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD133:** CD133 is a surface marker of glioma stem cells, with high expression in the GPC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD133:** CD133 is a surface marker of glioma stem cells, with high expression in the GPC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD133:** CD133 is a surface marker of glioma stem cells, with high expression in the GPC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD133:** CD133 is a surface marker of glioma stem cells, with high expression in the GPC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD133:** CD133 is a surface marker of glioma stem cells, with high expression in the GPC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD133:** CD133 is a surface marker of glioma stem cells, with high expression in the GPC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD133:** CD133 is a surface marker of glioma stem cells, with high expression in the GPC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD133:** CD133 is a surface marker of glioma stem cells, with high expression in the GPC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD133:** CD133 is a surface marker of glioma stem cells, with high expression in the GPC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD133:** CD133 is a surface marker of glioma stem cells, with high expression in the GPC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD133:** CD133 is a surface marker of glioma stem cells, with high expression in the GPC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD133:** CD133 is a surface marker of glioma stem cells, with high expression in the GPC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD133:** CD133 is a surface marker of glioma stem cells, with high expression in the GPC-like cell state of IDH-wildtype glioblastoma. It is a potential target for immunotherapy, as it is associated with the progenitor cell-like transcriptome.
- **CD133:** CD1
